Identification of essential genes for cancer immunotherapy

Immunotherapy

Immunotherapy in Gastrointestinal Cancers

Biomed Res Int.

Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, Zagonel V, Lonardi S

doi: 10.1155/2017/4346576.

Immunotherapy

Novel immunotherapy strategies for hepatobiliary cancers

Immunotherapy.

DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ

doi: 10.2217/imt-2018-0024.

T Cells

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Semin Cancer Biol.

Kumar P, Saini S, Prabhakar BS

doi: 10.1016/j.semcancer.

Immunotherapy

Is autoimmunity the Achilles' heel of cancer immunotherapy?

Nat Med.

June CH, Warshauer JT, Bluestone JA

doi: 10.1038/nm.4321.

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy

Crit Rev Oncol Hematol.

Solinas C, Porcu M, Hlavata Z, De Silva P, Puzzoni M, Willard-Gallo K, Scartozzi M, Saba L

doi: 10.1016/

Immunotherapy

Recent progress in therapeutic antibodies for cancer immunotherapy

doi: 10.1016/j.cbpa.2018.05.006.

Immunotherapy

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy

Trends Cancer.

Rufo N, Garg AD, Agostinis P

doi: 10.1016/j.trecan.2017.07.002.

RECOMMENDED

Immunotherapy

Development of a novel class of interleukin-2 immunotherapies for metastatic cancer

doi: smw.2019.14697.

NIH Partners With Drug Makers to Advance Cancer Immunotherapy

JAMA.

Lyon J

doi: 10.1001/jama.2017.17931.

Related content

Immunotherapy in Gastrointestinal Cancers

Novel immunotherapy strategies for hepatobiliary cancers

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Is autoimmunity the Achilles' heel of cancer immunotherapy?

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy

Recent progress in therapeutic antibodies for cancer immunotherapy

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy

Development of a novel class of interleukin-2 immunotherapies for metastatic cancer

NIH Partners With Drug Makers to Advance Cancer Immunotherapy